In individuals carrying the APOE E4 allele, higher cerebrospinal fluid (CSF) sTREM2 levels were prospectively correlated with reduced risks of AD, cognitive decline, and neurodegenerative diseases associated with APOE4 [31,35]. The gene discussed is APOE; the disease is Alzheimer disease.